General Information
Version
7.0
Revision date
2025-10-17
Product name
Fenbendazole Related Compound B
CAS No.
20367-38-8
Emergency telephone
+81 (0)3 4520 9637
Icons in SDS
Company Information
company name
Merck Ltd.
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H340, H360, H400, H410
Hazard statements
Code
Statements
H340
May cause genetic defects
Section 2
SECTION 2: Hazards identification
2.1 Classification of the substance or mixture
Germ cell mutagenicity, H340: May cause genetic defects. (Category 1A) Reproductive toxicity, (Category H360: May damage fertility or the unborn 1B) child. Short-term (acute) aquatic H400: Very toxic to aquatic life. hazard, (Category 1) Long-term (chronic) aquatic H410: Very toxic to aquatic life with long hazard, (Category 1) lasting effects.
Signal word
Danger Danger
Hazard statements
H340 May cause genetic defects. H360 May damage fertility or the unborn child. H410 Very toxic to aquatic life with long lasting effects. H340 May cause genetic defects. H360 May damage fertility or the unborn child.
Precautionary statements
P202 Do not handle until all safety precautions have been read and understood. P273 Avoid release to the environment. P280 Wear protective gloves/ protective clothing/ eye protection/ face protection. P308 + P313 IF exposed or concerned: Get medical advice/ attention. P391 Collect spillage. P405 Store locked up. P202 Do not handle until all safety precautions have been read and understood. P280 Wear protective gloves/ protective clothing/ eye protection/ face protection. P308 + P313 IF exposed or concerned: Get medical advice/ attention. P405 Store locked up.
Supplemental label elements
none Reduced Labelling (<= 125 ml) none
Other hazards
This substance/mixture contains no components considered to be either persistent, bioaccumulative and toxic (PBT), or very persistent and very bioaccumulative (vPvB) at levels of 0.1% or higher
ECOLOGICAL INFORMATION
The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher.
TOXICOLOGICAL INFORMATION
The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher.
